GenSight Biologics Announces its 2021 Money Calendar | Business enterprise & Finance
PARIS--(Business WIRE)--Jan 18, 2021--GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME suitable), a biopharma organization targeted on developing and commercializing...
